UNQ HOLDINGS (02177) Plans to Acquire Japanese Consultative Pharmacy Chain Akahige Pharmacy for ¥2.701 Billion

Stock News
2025/12/15

UNQ HOLDINGS (02177) announced that on December 15, 2025, its wholly-owned subsidiary, UNQ Japan Co., Ltd., intends to acquire a 90% stake in One Two Co., Ltd. for a total consideration of ¥2.701 billion. Upon completion, the target company will be indirectly held by UNQ HOLDINGS with approximately 90% ownership, making it an indirect non-wholly-owned subsidiary.

The target company is a limited liability company incorporated in Japan and operates Akahige Pharmacy, a leading consultative pharmacy chain specializing in sexual health and wellness. With over 33 years of market presence in Japan, Akahige Pharmacy operates more than nine locations across Hokkaido, Honshu, and Kyushu. Its core business focuses on providing personalized solutions for middle-aged and elderly men, addressing key sexual health concerns such as erectile dysfunction, premature ejaculation, and male menopause.

Beyond over-the-counter medications, Akahige Pharmacy has developed several patented sexual wellness products, including "Vigor King" and "Power Missile," aimed at supporting men's health and vitality.

UNQ HOLDINGS believes the acquisition will strengthen its foothold in Japan's pharmacy sector by leveraging Akahige Pharmacy's nationwide retail network. Additionally, the group expects synergies from the target company's established relationships with Japanese suppliers and logistics networks, aligning with its broader business strategy.

Post-acquisition, UNQ HOLDINGS plans to reassess and optimize the target company's financial position, potentially divesting non-core assets and reinvesting proceeds into new patented product development and brand expansion.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10